Medline IPO
Medline is one of the largest private medical supply companies in the U.S., manufacturing and distributing products to hospitals, surgery centers, and clinics nationwide. The company generates over $20 billion in annual revenue. Medline has been exploring an IPO that could value it at $50 billion or more.
Key Facts
| Industry | Medical Device Distribution |
| Founded | 1966 |
| Headquarters | Northfield, IL |
| Employees | ~27,000 |
| Website | medline.com |
| Funding | Completed $6.3 billion IPO (2026); Previously acquired by Blackstone, Carlyle, and Hellman & Friedman at $34B valuation (2021) |
About Medline
Medline Industries is one of the largest privately-held manufacturers and distributors of medical supplies and healthcare products in the United States, serving hospitals, surgery centers, extended care facilities, and other healthcare providers with a comprehensive portfolio of medical devices, surgical instruments, and healthcare supplies. The company operates manufacturing facilities globally and maintains an extensive distribution network that enables rapid delivery of critical medical products to healthcare facilities nationwide.
Medline has built its market position through a combination of private-label manufacturing, strategic partnerships with healthcare systems, and value-added services including inventory management, clinical education, and supply chain optimization. The company's business model focuses on providing cost-effective medical products while offering customized solutions that help healthcare providers improve operational efficiency and patient outcomes. With healthcare costs under continued scrutiny and supply chain reliability becoming increasingly critical, Medline's integrated approach to medical product manufacturing and distribution has positioned it as an essential partner to healthcare systems seeking to optimize their procurement and inventory management processes.
IPO Status
Medline has successfully completed its IPO and is now trading publicly. The healthcare supply company raised $6.3 billion in what became the year's biggest IPO, with shares popping 20% in early trading. This marks a significant milestone for one of the largest private companies in the U.S., which has over $20 billion in annual revenue. The company had been backed by private equity sponsors including Blackstone, Carlyle, and Hellman & Friedman since 2021. The IPO had been previously explored with potential valuations of $50 billion or more, and the company has now successfully transitioned from private to public ownership through this major public offering.
Competitors
Frequently Asked Questions
Does Medline have a stock?
As of early 2026, there is no confirmed IPO filing for Medline. There has been media speculation about a potential public listing, but the company has not made any official announcements.
When is the Medline IPO date?
No Medline IPO date has been announced. While there has been speculation about a potential listing, no timeline has been confirmed.
How can I buy Medline stock?
Medline is not yet publicly traded and there is no confirmed IPO timeline. If the company does go public, you'll be able to buy shares through any major brokerage.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts